Suivre
Alexandre Cochet
Alexandre Cochet
Adresse e-mail validée de u-bourgogne.fr
Titre
Citée par
Citée par
Année
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
M Van Kranenburg, M Magro, H Thiele, S de Waha, I Eitel, A Cochet, ...
JACC: Cardiovascular Imaging 7 (9), 930-939, 2014
3572014
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131I ablation therapy in patients with differentiated …
M Toubeau, C Touzery, P Arveux, G Chaplain, G Vaillant, A Berriolo, ...
Journal of Nuclear Medicine 45 (6), 988-994, 2004
2402004
In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic …
L Berthet, A Cochet, S Kanoun, A Berriolo-Riedinger, O Humbert, ...
Journal of Nuclear Medicine 54 (8), 1244-1250, 2013
2062013
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
A Berriolo-Riedinger, C Touzery, JM Riedinger, M Toubeau, B Coudert, ...
European journal of nuclear medicine and molecular imaging 34, 1915-1924, 2007
1992007
18F-FDG PET/CT for staging and restaging of breast cancer
D Groheux, A Cochet, O Humbert, JL Alberini, E Hindié, D Mankoff
Journal of Nuclear Medicine 57 (Supplement 1), 17S-26S, 2016
1852016
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
S Kanoun, C Rossi, A Berriolo-Riedinger, I Dygai-Cochet, A Cochet, ...
European journal of nuclear medicine and molecular imaging 41, 1735-1743, 2014
1732014
Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F] FDG PET to predict survival in Hodgkin lymphoma
S Kanoun, I Tal, A Berriolo-Riedinger, C Rossi, JM Riedinger, ...
PloS one 10 (10), e0140830, 2015
1112015
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes
O Humbert, A Berriolo-Riedinger, JM Riedinger, B Coudert, L Arnould, ...
Annals of oncology 23 (10), 2572-2577, 2012
1082012
Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction
AA Cochet, L Lorgis, A Lalande, M Zeller, JC Beer, PM Walker, C Touzery, ...
European radiology 19, 2117-2126, 2009
842009
18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
A Cochet, I Dygai-Cochet, JM Riedinger, O Humbert, A Berriolo-Riedinger, ...
European journal of nuclear medicine and molecular imaging 41, 428-437, 2014
812014
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer
A Cochet, G Quilichini, I Dygai-Cochet, C Touzery, M Toubeau, ...
Breast cancer research and treatment 130, 845-854, 2011
752011
HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
O Humbert, A Cochet, JM Riedinger, A Berriolo-Riedinger, L Arnould, ...
European journal of nuclear medicine and molecular imaging 41, 1525-1533, 2014
742014
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer
O Humbert, A Berriolo-Riedinger, A Cochet, M Gauthier, C Charon-Barra, ...
European journal of nuclear medicine and molecular imaging 41, 416-427, 2014
712014
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors
A Cochet, S Pigeonnat, B Khoury, JM Vrigneaud, C Touzery, ...
Journal of Nuclear Medicine 53 (4), 512-520, 2012
712012
Role of positron emission tomography for the monitoring of response to therapy in breast cancer
O Humbert, A Cochet, B Coudert, A Berriolo-Riedinger, S Kanoun, ...
The oncologist 20 (2), 94-104, 2015
702015
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
O Humbert, JM Riedinger, C Charon-Barra, A Berriolo-Riedinger, ...
Clinical Cancer Research 21 (24), 5460-5468, 2015
692015
Emidec: a database usable for the automatic evaluation of myocardial infarction from delayed-enhancement cardiac MRI
A Lalande, Z Chen, T Decourselle, A Qayyum, T Pommier, L Lorgis, ...
Data 5 (4), 89, 2020
642020
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
G Crehange, M Roach III, E Martin, L Cormier, D Peiffert, A Cochet, ...
Cancer/Radiothérapie 18 (5-6), 524-534, 2014
602014
The extent of myocardial damage assessed by contrast‐enhanced MRI is a major determinant of N‐BNP concentration after myocardial infarction
A Cochet, M Zeller, Y Cottin, C Robert‐Valla, A Lalande, I L'Huilllier, ...
European Journal of Heart Failure 6 (5), 555-560, 2004
532004
Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI
A Comte, A Lalande, PM Walker, A Cochet, L Legrand, Y Cottin, JE Wolf, ...
European radiology 14, 2182-2187, 2004
502004
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20